Patient Reported Outcomes

This area focuses on advancing patient focused therapy development in rare disease by appropriately incorporating user perspectives to develop a PRO support service for trial design.

Research lead

Assoc. Prof Olalekan Lee Aigegbusi

Lee is an Associate Professor and Deputy Director, at the Centre for Patient-Reported Outcome Research (CPROR), Department of Applied Health Sciences, University of Birmingham. He is also a co-Lead for the patient-reported outcome (PRO) theme of the Birmingham NIHR BRC and his research focuses on the optimisation of patient-reported outcomes (PRO) assessments for clinical research, routine clinical practice, and regulatory purposes. He is the Patient and Public Involvement and Engagement (PPIE) Lead for various research projects including the NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics (BTRU-PCT).

University lead

Prof. David Jones - Newcastle University

Alongside being the Centre Coordinator, Prof David Jones is the Newcastle centre lead for Patient Reported Outcomes. He is an active researcher in autoimmune liver disease with a focus on improving outcomes through evaluation of new treatments.

Dr Noleen McCorry – Queens University, Belfast

Dr McCorry is a Chartered Psychologist, with expertise in health services research and health psychology. Noleen has a focus on the evaluation and implementation of Psychosocial interventions for people with long term conditions.

Area Overview

Ensuring that patient perspectives are integrated into clinical trials is essential for developing effective, patient-centred therapies for rare diseases. This research area focuses on optimising methods to capture efficacy and safety data, ensuring that Patient-Reported Outcomes (PROs) are inclusive and relevant to all members of society.

By working closely with patients, advocacy groups, and stakeholders, we will establish consensus-based guidance to standardise PRO collection and ensure its acceptability, accessibility, and impact on trial design.

Through multistakeholder workshops, literature reviews, focus groups, and Delphi surveys, we will identify barriers and facilitators to PRO collection in rare disease trials. These insights will support the development of a PRO design support service, providing rare disease researchers with the tools and guidance needed to effectively implement patient-focused outcome measures in their studies.

By embedding PRO methodologies into trial design, this initiative will help ensure that clinical research captures what truly matters to patients, leading to more meaningful trial outcomes, improved patient engagement, and enhanced treatment decision-making.

Interested in working with the team?

We are always looking for talented researchers, clinicians, and industry partners to join our efforts in accelerating rare disease trials. Whether you’re interested in research collaboration, clinical trial design, or patient engagement, we’d love to hear from you.